Independent Pharmacies Are Well-positioned to Vaccinate Their Communities Against COVID-19
January 20th 2021Pharmacy Times® interviewed Thomas D’Angelo, RPh, president of the Pharmacists Society of the State of New York, on how independent pharmacies may be well-positioned to assist in the administration of COVID-19 vaccines.
Walgreens Pharmacies Will Have 45,000 Trained COVID-19 Immunizers in the Next 90 Days
January 19th 2021Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on how the hours of operation of pharmacies involved in the COVID-19 vaccinations have been impacted by vaccination efforts.
Walgreens’ Plans to Provide COVID-19 Vaccine Access in Medically Underserved Communities
January 18th 2021Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on Walgreens’ plans to provide access to COVID-19 vaccines among vulnerable populations in medically underserved communities.
How President-elect Biden’s Cabinet Nominations May Impact Pharmacy This Year
January 16th 2021Pharmacy Times® interviewed Chad Landmon, the chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, on the potential impact President-elect Joseph Biden’s cabinet nominations may have on the pharmacy field in 2021.
Anticipating Problems During First Wave of COVID-19 Vaccinations
January 14th 2021Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on whether any unforeseen problems have arisen during the first wave of COVID-19 vaccinations at long-term care facilities.
Planning, Implementing Walgreens’ COVID-19 Vaccination Program at Long-term Care Facilities
January 13th 2021Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the first wave of COVID-19 vaccine administration at long-term care facilities across the country.
The Enforcement of 340B Drug Pricing Laws May Change Under the Biden Administration
January 8th 2021Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on a letter that was signed by President-elect Biden’s pick for HHS secretary to the outgoing HHS secretary on the enforcement of 340B drug pricing laws.